Language

News topic

Start: 2025-03

All current shortage notices related to Start: 2025-03, structured by product, country, active ingredient and reporting period.

16 notices

← All shortages

Germany

Pramipexol - 1 A Pharma 0,26 mg Retardtabletten

Active ingredient: Pramipexoldihydrochlorid-Monohydrat

View notice details →
Belgium

Mitomycin Accord Healthcare 10 mg inj./inf. sol. (pwdr.)/i.vesic. sol. (pwdr.) i.v. vial 5 x 10 mg

Active ingredient: Mitomycin

View notice details →
Germany

Galantamin-ratiopharm 8 mg Hartkapseln, retardiert

Active ingredient: Galantaminhydrobromid

View notice details →
Germany

Galantamin-ratiopharm 24 mg Hartkapseln, retardiert

Active ingredient: Galantaminhydrobromid

View notice details →
Belgium

Dermestril-Septem 25 µg/24 h transderm. patch 12 (2,5 mg/11,25 cm²)

Active ingredient: Estradiol

View notice details →
Belgium

Nexviadyme 100 mg inj. sol. (pwdr., conc.) i.v. vial 10 x 100 mg

Active ingredient: Avalglucosidase Alfa

View notice details →
Belgium

Solifenacin Krka 5 mg film-coat. tabl. 250

Active ingredient: Solifenacin

View notice details →
Belgium

Solifenacin Krka 10 mg film-coat. tabl. 250

Active ingredient: Solifenacin

View notice details →
Germany

Galantamin-ratiopharm 24 mg Hartkapseln, retardiert

Active ingredient: Galantaminhydrobromid

View notice details →
Austria

Quetiapin neuraxpharm 300 mg Retardtabletten

Active ingredient: QUETIAPIN FUMARAT

View notice details →
Austria

Quetialan XR 300 mg-Retardtabletten

Active ingredient: QUETIAPIN FUMARAT

View notice details →
Belgium

Dermestril-Septem 25 µg/24 h transderm. pleister 12 (2,5 mg/11,25 cm²)

Active ingredient: Estradiol

View notice details →
Austria

Nexviadyme 100 mg Pulver für ein Konzentrat zur Herstellung einer Infusionslösung

Active ingredient: AVALGLUCOSIDASE ALFA

View notice details →

Plan supply. Connect sourcing and warehousing.

For pharmacies, wholesalers and manufacturers: choose the service matching your operational need.